Shikiar Asset Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-715
Closed -$528K 103
2017
Q3
$528K Sell
715
-990
-58% -$822K 0.23% 64
2017
Q2
$1.48M Sell
1,705
-3,665
-68% -$3.07M 0.64% 39
2017
Q1
$4.56M Sell
5,370
-850
-14% -$704K 2.06% 20
2016
Q4
$4.74M Sell
6,220
-385
-6% -$291K 2.08% 22
2016
Q3
$5.43M Buy
6,605
+520
+9% +$449K 2.41% 14
2016
Q2
$5.07M Buy
6,085
+1,440
+31% +$1.2M 2.26% 19
2016
Q1
$4.27M Buy
4,645
+305
+7% +$292K 1.97% 21
2015
Q4
$4.47M Buy
4,340
+545
+14% +$547K 2.16% 19
2015
Q3
$3.58M Sell
3,795
-390
-9% -$407K 1.85% 21
2015
Q2
$4.38M Buy
+4,185
New +$4.38M 2% 18

Other funds holding AGN.PRA

Shikiar Asset Management's AGN.PRA Position: Q4 2017 in Review

Shikiar Asset Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 715 shares — an estimated $528K sold.

Shikiar Asset Management first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $5.43M in Q3 2016. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Shikiar Asset Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Shikiar Asset Management sold 715 Allergan plc shares in Q4 2017, an estimated $528K.
  • Shikiar Asset Management first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Shikiar Asset Management's Allergan plc position peaked at $5.43M in Q3 2016.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Shikiar Asset Management's 13F filing for Q4 2017, filed 26 Jan 2018.